ENTITY
Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals (GLXO IN)

29
Analysis
Health Care • India
Glaxosmithkline Pharmaceuticals Ltd. manufactures and distributes a wide variety of pharmaceutical drugs, veterinary products and laboratory chemicals. The Company's products include "Phexin" capsules, "Betnesol" tablets and injections, "Becoride" asthma treatment, "Betnovate" ointment, "Cetzine" antihistamine, "Zucox" and "Rizap" anti-tuberculosis products.
more
bullish•Mankind Pharma
•08 Feb 2023 09:48

Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins

Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.

Logo
589 Views
Share
•03 Jul 2024 10:10

Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO. In this note, we talk about valuations.

Logo
2.6k Views
Share
bullish•Mankind Pharma
•12 Dec 2023 09:58

Mankind Pharma Placement - Its Expensive, but at Least It’s High Quality

A group of shareholders is looking to raise around US$600m via selling a 6.9% stake in Mankind Pharma. We had looked at the lockup release earlier.

Logo
643 Views
Share
bullish•Mankind Pharma
•08 May 2023 12:45

Mankind Pharma IPO Trading - Strong Insti Demand Makes up for Retail Lag

Mankind Pharma  raised around US$527m in its upcoming India IPO. In this note, we talk about the demand updates and the trading dynamics.

Logo
509 Views
Share
bullish•Mankind Pharma
•19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
581 Views
Share
x